» Articles » PMID: 1495304

Accuracy of Computed Tomographic Scan and Surgical Assessment for Staging of Bronchial Carcinoma. A Prospective Study

Overview
Date 1992 Aug 1
PMID 1495304
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

There is an increasing demand for accurate preoperative and intraoperative staging of bronchial carcinoma with respect to neoadjuvant therapy protocols and parenchyma-sparing operations. This study prospectively evaluated accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma in 108 consecutive patients. The stage of the primary tumor (T stage) was correctly determined in 85% of the patients, and surgical evaluation correctly determined the T stage in 92%. Invasion of major mediastinal structures posed a major problem for computed tomographic scan. On a node-by-node basis, computed tomographic scan predicted involvement of lymph nodes in 81% (sensitivity 29%, specificity 93%, positive predictive value 49%, negative predictive value 85%). The surgeon correctly determined the lymph node status in 69% of lymph nodes (sensitivity 90%, specificity 63%, positive predictive value 39%, negative predictive value 96%). On a patient-by-patient basis, computed tomographic scan correctly predicted the nodal status in 58% of patients. Accuracy of computed tomographic scan and surgical assessment in determination of the lymph node status strongly depended on tumor type and lymph node region (hilar or mediastinal region) studied. This was partly due to the fact that adenocarcinomas exhibited a high proportion of tumor-positive normal-sized lymph nodes, whereas squamous cell carcinomas showed a high proportion of enlarged tumor-free lymph nodes. In conclusion, computed tomographic scan and surgical assessment are sufficiently accurate for determination of the tumor stage but are insufficient in determining the nodal status.

Citing Articles

Predictors for hilar/intrapulmonary lymph node metastasis in discrete type of clinical N1 non-small cell lung cancer.

Fukui T, Kato K, Okasaka T, Kawaguchi K, Fukumoto K, Nakamura S Gen Thorac Cardiovasc Surg. 2017; 65(11):640-645.

PMID: 28866794 DOI: 10.1007/s11748-017-0827-4.


Yield of endoscopic ultrasound-guided fine needle aspiration for subcentimetric lymph nodes: A comparison to larger nodes.

Choudhary N, Bodh V, Kumar N, Puri R, Sarin H, Guleria M Endosc Ultrasound. 2017; 6(3):168-173.

PMID: 28621293 PMC: 5488519. DOI: 10.4103/2303-9027.208151.


Nodal involvement pattern in resectable lung cancer according to tumor location.

Saeteng S, Tantraworasin A, Euathrongchit J, Lertprasertsuke N, Wannasopha Y Cancer Manag Res. 2012; 4:151-8.

PMID: 22740775 PMC: 3379857. DOI: 10.2147/CMAR.S30526.


Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Reck M, Barlesi F, Crino L, Henschke C, Isla D, Stiebeler S Ann Oncol. 2011; 23(5):1111-1120.

PMID: 22056855 PMC: 3335247. DOI: 10.1093/annonc/mdr463.


Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis.

Miyoshi K, Mimura T, Iwanaga K, Adachi S, Tsubota N, Okada M Surg Today. 2010; 40(5):428-32.

PMID: 20425545 DOI: 10.1007/s00595-008-4072-4.